Carregant...
Natalizumab (Tysabri)
Natalizumab is a humanized IgG4κ monoclonal antibody that is a selective adhesion molecule inhibitor, which prevents adhesion of leukocytes to endothelial cells. It is the first monoclonal antibody approved by the FDA for the treatment of relapsing-remitting MS. This article will review the mechanis...
Guardat en:
| Publicat a: | AJNR Am J Neuroradiol |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society of Neuroradiology
2010
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7964985/ https://ncbi.nlm.nih.gov/pubmed/20688889 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3174/ajnr.A2226 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|